Mayukh Sukhatme is President & CIO at Roivant Sciences Ltd. (ROIV). They have made 8 open-market trades across 1 company since 2024, most recently 2026-09-30.
CIK 0001750050
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ROIV | 18,583,860 | $622.7M |
Shares reported on the most recent Form 4, priced at the 2026-10-02 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ROIV | SELL | 2026-08-19 | 2026-08-21 | $36.88 | $12.4M | -5.4% | +7.8% | — |
| ROIV | SELL | 2026-08-14 | 2026-08-18 | $36.34 | $24.2M | -8.5% | +5.4% | — |
| ROIV | SELL | 2026-06-25 | 2026-06-29 | $34.11 | $34.1M | +3.4% | -5.5% | +6.4% |
| ROIV | SELL | 2026-02-09 | 2026-02-11 | $26.47 | $9.0M | +5.3% | +4.5% | +9.5% |
| ROIV | SELL | 2025-12-29 | 2025-12-31 | $21.72 | $57.8M | +8.0% | -0.4% | +27.6% |
| ROIV | SELL | 2025-12-17 | 2025-12-19 | $23.09 | $1.2M | -1.2% | +3.5% | +25.2% |
| ROIV | SELL | 2024-12-23 | 2024-12-26 | $12.01 | $18.9M | -7.6% | -6.6% | -12.5% |
| ROIV | SELL | 2024-12-18 | 2024-12-20 | $12.05 | $9.9M | +0.3% | -3.3% | -5.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.